On this episode of the Health & Veritas podcast, Howard Forman and Harlan Krumholz are joined by Dr. James Hamblin, a journalist and a lecturer at the Yale School of Public Health. They discuss his approach to communicating about public health, his prescient February 2020 article on COVID-19, and why he’s quit taking showers.
The COVID-19 crisis has intensified the debate over big data and privacy. Governments are pulling together data from public and private systems in order to predict and counter the spread of COVID-19. But setting aside privacy protections in a time of crisis could lead to new, permanent norms.
A team of Yale researchers says we should all be wearing cloth masks, but give the surgical masks to healthcare workers.
The mass social distancing strategy being used to mitigate the spread of COVID-19 in the United States and Europe doesn’t easily translate to a developing country like Bangladesh, which lacks the capacity to impose restrictions or provide a social safety net for the unemployed.
Companies often purchase competitors, not to acquire their ideas and products, but to shut them down. A recent report raised questions about whether such an acquisition may be partially responsible for a shortage of ventilators in the United States.
As pharmaceutical companies work to develop potential vaccines and treatments for COVID-19, they are operating under extreme pressure—as well as the restrictions on movement and interaction that are affecting all of us.
A greater share of Americans filed for unemployment insurance in the week ending March 21 than in any prior week in American history. We asked Yale SOM's Paul Goldsmith-Pinkham for his perspective on this alarming statistic.
Yale SOM’s Michael Kraus and Eunice Eun argue that anti-Asian bias provoked by COVID-19 reveals the ongoing influence of racism in the country.
On March 24, experts in finance, economics, and health from Global Network schools in seven countries gathered for an online conversation about the state of the COVID-19 pandemic, the economic fallout, and the path to recovery.
What will the sudden economic shock mean for competition and antitrust policy? We asked Yale SOM’s Fiona Scott Morton, an economist who served in the Antitrust Division of the U.S. Department of Justice, for her perspective.
In a Fortune commentary, Dr. Michael Apkon ’02, president and CEO of Tufts Medical Center, and Yale SOM’s Dr. Howard Forman and Jeffrey Sonnenfeld write that such an approach would be dangerous and ineffective.